Patent details
LUC00043
Product Name:
Rolapitant, optionally in the form of a pharmaceutically acceptable salt, including rolapitant hydrochloride monohydrate
Basic Information
- Publication number:
- LUC00043
- Type:
- SPC
- SPC Type:
- Medical
- Basic Patent Number:
-
EP028051670
- Legal Status:
- Invalid
- Application number:
- LUC00043
- First applicant's nationality:
- Procedural language:
- French
Marketing Authorization
- Marketing Authorization Number:
- EU/1/17/1180/001
- Marketing Authorization Type:
-
- Marketing Authorization Date:
- 24/04/2017
- Marketing Authorization Status:
- Accepted
- Marketing Authorization Country:
- Luxembourg (LU)
Dates
- Filing date:
- 11/10/2017
- First Marketing Authorization date:
- 24/04/2017
- Grant date:
- 20/12/2017
- Activation date:
- Publication date:
- 16/10/2017
- Lapsed date:
- Expiration date:
- Renunciation date:
- Revocation date:
- Annulment date:
- Basic SPC Expiration:
- 17/12/2027
- SPC Extension Expiration:
- 17/12/2027
- Rejection date:
- Withdrawal date:
Owner
- From:
- 11/10/2017
-
-
- Name:
- Tesaro, Inc.
- Address:
- 1000 Winter St. North, Waltham, Massachusetts 02451, United States (US)
Agent
- Name:
- DENNEMEYER & ASSOCIATES S.A. PATENT DEPARTMENT
- From:
- 11/10/2017
- Address:
- PO Box 1502, 1015, LUXEMBOURG, Luxembourg (LU)
- To:
Publication
Bulletin
1
- Bulletin Heading:
- SPC1
- Bulletin edition number:
- 2017/07
- Publication date:
- 11/12/2017
- Description:
- Section C : Published requests for Supplementary Protection Certificates – I1 publication
2
- Bulletin Heading:
- SPC2
- Bulletin edition number:
- 2018/02
- Publication date:
- 15/01/2018
- Description:
- Section D : Granted supplementary protection certificates – I2 publication
Annual Fees
- Annual Fee Due Date:
- 02/01/2023
- Annual Fee Number:
- 21
- Annual Fee Amount:
- 410 Euro
- Expected Payer:
-
- Last Annual Fee Payment Date:
-
- Last Annual Fee Paid Number:
-
- Payer:
-